Dr Michelle Lane is currently the Chief Scientific Officer for the Monash IVF Group (which Repromed is a part of) and a Senior Lecturer with the Research Centre for Reproductive Health. She received her Ph.D. in December 1996 and then spent 2 years at the University of Wisconsin as a post-doctoral fellow before moving to take up a Senior Scientist position at the Colorado Center for Reproductive Medicine. She has combined her research appointments with clinical embryology since 1992 when she moved to a scientific advisor role to 2 clinics in the USA and then Scientific Director. At the end of 2003, Dr. Lane returned to Australia at the University of Adelaide to establish a clinical orientated research program in the area of mammalian embryology and oocyte biology. In 2004 she was awarded a ‘Tall Poppy’ award for recognition of excellence for young biomedical researchers in South Australia. In 2005, she began as a NHMRC RD Wright Fellow. Dr. Lane has published extensively in the area of preimplantation embryology and has co-authored 51 premier peer-reviewed journals (including Nature Biotechnology, Journal of Biological Chemistry, Developmental Biology and Biology of Reproduction, the highest impact factor reproduction journal), 11 review articles, edited 2 books and written 17 book chapters. Her intellectual input into this published research is demonstrated by the number of first and last author publications attributed to her (53 publications). Dr. Lane is an innovative researcher with extensive experience in intellectual property protection and commercialisation as evidenced by being an inventor on several different patent applications Dr. Lane has established herself as a highly motivated researcher with a growing international reputation.